Researchers are continuing to explore how psilocybin affects various brain networks and how it can potentially benefit people with depression.
U.K.-based Small Pharma is conducting a study of DMT and its potential for treating major depressive disorder.
Researchers are continuing to explore how psilocybin affects various brain networks and how it can potentially benefit people with depression.
U.K.-based Small Pharma is conducting a study of DMT and its potential for treating major depressive disorder.
Get notified of our the latest cannabis news, exclusive brand deals, events updates and more!